Clinical Investigation

Kidney International (1992) 41, 1311–1319; doi:10.1038/ki.1992.195

Factors affecting the progression of renal disease in autosomal-dominant polycystic kidney disease

Patricia A Gabow, Ann M Johnson, William D Kaehny, William J Kimberling, Dennis C Lezotte, Irene T Duley and Richard H Jones

Department of Medicine and Department of Preventive Medicine and Biometrics, University of Colorado Health Sciences Center, and Department of Medicine, Veteran Affairs Medical Center, Denver, Colorado; Boys Town National Institute, Omaha, Nebraska, USA

Correspondence: Patrica A Gabow MD, PKD Research, Box C283, University of Colorado Health Sciences Center, 4200 East 9th Avenue, Denver, Colorado 80262, USA.

Received 13 July 1991; Revised 4 November 1991; Accepted 8 November 1991.

Top

Abstract

Factors affecting the progression of renal disease in autosomal-dominant polycystic kidney disease. Autosomal-dominant polycystic kidney disease results in renal failure at a varying age from childhood to old age. We postulated that factors other than the culprit gene alone contribute to the course of progression of the renal failure. We studied 580 subjects with autosomal-dominant polycystic kidney disease and 194 unaffected family members. We calculated survival curves to end-stage renal failure or death and developed a linear model for testing the effects of single or multiple variables on the progression of renal failure as estimated from the reciprocal of serum creatinine. Fifty-two subjects died and 94 reached end-stage renal failure during the period of observation, yielding functional survivals of 71% at age 50 years, 53% at 58 years and 23% at 70 years. The following variables were independently associated with worse mean renal function at a given age (P value less than 0.01): the PKD1 gene, younger age at diagnosis, male gender, hypertension, increased left ventricular mass, hepatic cysts in women, three or more pregnancies, gross hematuria, urinary tract infections in men and renal size expressed as renal volume. The following were not associated significantly with the course of renal function: gender of affected parent, mitral valve prolapse, intracranial aneurysms, any pregnancy, hepatic cysts in men and urinary tract infections in women. The identification of unalterable maleficent factors such as the PKD1 gene and male gender permit more informed counseling while the identification of alterable factors such as hypertension, number of pregnancies and recurrent urinary tract infections provides the clinician with the opportunity to modify these factors and improve the management of patients with autosomal-dominant polycystic kidney disease.

Top

References

  1. Churchill DN, Bear JC, Morgan J, Payne RH, McManamon PJ, Gault MH: Prognosis of adult onset polycystic kidney disease reevaluated. Kidney Int 26:190–193, 1984 | PubMed | ISI | ChemPort |
  2. Parfrey PS, Bear JC, Morgan J, Cramer BC, McManamon PJ, Gault MH, Churchill DN, Singh M, Hewitt R, Somlo S, Reeders ST: The diagnosis and prognosis of autosomal dominant polycystic kidney disease. N Engl J Med 323:1085–1090, 1990 | PubMed | ISI | ChemPort |
  3. Gabow PA, Kaehny WD, Johnson AM, Duley IT, Manco-Johnson M, Lezotte DC, Schrier RW: The clinical utility of renal concentrating capacity in polycystic kidney disease. Kidney Int 35:675–680, 1989 | PubMed | ISI | ChemPort |
  4. Gabow PA, Ikle DW, Holmes JH: Polycystic kidney disease: Prospective analysis of nonazotemic patients and family members. Ann Intern Med 101:238–247, 1984 | PubMed | ISI | ChemPort |
  5. Reeders ST, Breuning MH, Davies KE, Nicholls RD, Jarman AP, Higgs DR, Pearson PL, Weatherall DJ: A highly polymorphic DNA marker linked to adult polycystic kidney disease on chromosome 16. Nature 317:542–544, 1985 | Article | PubMed | ISI | ChemPort |
  6. Kimberling WJ, Pieke SA, Kenyon JB, Gabow PA: An estimate of the proportion of families with autosomal dominant polycystic kidney disease unlinked to chromosome 16. (abstract) Kidney Int 37:249, 1990
  7. Kimberling WJ, Fain PR, Kenyon JB, Goldgar D, Sujansky E, Gabow PA: Linkage heterogeneity of autosomal dominant polycystic kidney disease. N Engl J Med 319:913–918, 1988 | ChemPort |
  8. Hossack KF, Leddy CL, Johnson AM, Schrier RW, Gabow PA: Echocardiographic findings in autosomal dominant polycystic kidney disease. N Engl J Med 319:907–912, 1988 | PubMed | ISI | ChemPort |
  9. Devereux RB, Reichek N: Echocardiographic determination of left ventricular mass in man: Anatomic validation of the method. Circulation 55:613–618, 1977 | PubMed | ISI | ChemPort |
  10. Kaplan EL, Meier P: Nonparametric estimation from incomplete observations. J Am Stat Assoc 53:457–481, 1958 | Article | ISI |
  11. Jones RH, Boadi-Boateng F: Unequally spaced longitudinal data with AR(1) serial correlation. Biometrics 47:161–175, 1991
  12. Mitch WE, Walser M, Buffington GA, Lemann J Jr: simple method of estimating progression of chronic renal failure. Lancet 2:1326–1328, 1976 | PubMed | ISI | ChemPort |
  13. Franz KA, Reubi FC: Rate of functional deterioration in polycystic kidney disease. Kidney Int 23:526–529, 1983 | PubMed | ISI | ChemPort |
  14. Akaike H: A new look at the statistical model identification. IEEE Trans on Automatic Control 19:716–723, 1974
  15. Levey AS, Perrone RD, Madias NE: Serum creatinine and renal function. Annu Rev Med 39:465–490, 1988 | Article | PubMed | ISI | ChemPort |
  16. Sedman A, Bell P, Manco-Johnson M, Schrier R, Warady BA, Heard EO, Butler-Simon N, Gabow P: Autosomal dominant polycystic kidney disease in childhood: A longitudinal study. Kidney Int 31:1000–1005, 1987 | PubMed | ISI | ChemPort |
  17. Gabow PA, Johnson AM, Kaehny WD, Manco-Johnson ML, Duley IT, Everson GT: Risk factors for the development of hepatic cysts in autosomal dominant polycystic kidney disease. Hepatology 11:1033–1037, 1990 | PubMed | ISI | ChemPort |
  18. Dalgaard OZ: Bilateral polycystic disease of the kidneys: A follow-up of two hundred and eighty-four patients and their families. Acta Med Scand (Suppl) 328:1–25, 1957
  19. Cole BR, Conley SB, Stapleton FB: Polycystic kidney disease in the first year of life. J Pediatr 111:693–699, 1987 | PubMed | ISI | ChemPort |
  20. Milutinovic J, Fialkow PJ, Agodoa LY, Phillips LA, Rudd TG, Bryant JI: Autosomal dominant polycystic kidney disease: Symptoms and clinical findings. Q J Med 53:511–522, 1984 | PubMed |
  21. Gretz N, Zeier M, Geberth S, Strauch M, Ritz E: Is gender a determinant for evolution of renal failure? A study in autosomal dominant polycystic kidney disease. Am J Kidney Dis 14:178–183, 1989 | PubMed | ISI | ChemPort |
  22. Gattone VH II, Kraybill AL, Gudapaty S, Kaspareit-Rittinghausen J, Cowley BD Jr: Autosomal dominant polycystic kidney disease in the rat. (abstract) J Am Soc Nephrol 1:629, 1990
  23. Oppenheimer GD: Polycystic disease of the kidney. Ann Surg 100:1136–1158, 1934
  24. Iglesias CG, Torres VE, Offord KP, Holley KE, Beard CM, Kurland LT: Epidemiology of adult polycystic kidney disease, Olmstead County, Minnesota: 1935–1980. Am J Kidney Dis 2:630–639, 1983
  25. Hansson L, Karlander L-E, Lundgren W, Peterson L-E: Hypertension in polycystic kidney disease. Scand J Urol Nephrol 8:203–205, 1974 | PubMed | ISI | ChemPort |
  26. Parfrey PS, Morgan J, Singh M, Cramer B, Bear J: Autosomal dominant polycystic kidney disease in children. (abstract) Kidney Int 35:206, 1989
  27. Brazy PC, Stead WW, Fitzwilliam JF: Progression of renal insufficiency: Role of blood pressure. Kidney Int 35:670–674, 1989 | PubMed | ISI | ChemPort |
  28. Zeier M, Fehrenbach P, Geberth S, Waldherr R, Ritz E: Mechanisms of progression in autosomal dominant polycystic kidney disease—A histological study. (abstract) J Am Soc Nephrol 1:297, 1990
  29. Gabow PA, Chapman AB, Johnson AM, Tangel DT, Duley IT, Kaehny WD, Manco-Johnson M, Schrier RW: Renal structure and hypertension in autosomal-dominant polycystic kidney disease. Kidney Int 38:1177–1180, 1990 | Article | PubMed | ISI | ChemPort |
  30. Milutinovic J, Fialkow PJ, Agodoa LY, Phillips LA, Bryant JI: Fertility and pregnancy complications in women with autosomal dominant polycystic kidney disease. Obstet Gynecol 61:566–570, 1983
  31. Chapman AB, Johnson AM, Gabow PA: Maternal and fetal outcomes of pregnancy in autosomal dominant polycystic kidney disease. (abstract) XIth International Congress of Nephrology, Tokyo, Japan, 1990
  32. Alfrey AC, Froment DH, Hammond WS: Role of iron in the tubulo-interstitial injury in nephrotoxic serum nephritis. Kidney Int 36:753–759, 1989 | PubMed | ISI | ChemPort |
  33. Schwab SJ, Bander SJ, Klahr S: Renal infection in autosomal dominant polycystic kidney disease. Am J Med 82:714–718, 1987 | Article | PubMed | ISI | ChemPort |
  34. Bennett WM, Elzinga L, Golper TA, Barry JM: Reduction of cyst volume for symptomatic management of autosomal dominant polycystic kidney disease. J Urol 137:620–622, 1987 | PubMed | ISI | ChemPort |
  35. Bennett W, Barry J, Elzinga L, Golper T, Torres V: Renal functional and symptomatic responses to reducing cyst volume in patients with autosomal dominant polycystic kidney disease. (abstract) Kidney Int 33:181, 1988
  36. Mangoo-Karim R, Uchic M, Lechene C, Grantham JJ: Renal epithelial cyst formation and enlargement in vitro: Dependence on cAMP. Proc Natl Acad Sci USA 86:6007–6011, 1989 | PubMed | ChemPort |
  37. Grantham JJ, Uchic M, Cragoe EJ Jr, Kornhaus J, Grantham JA, Donoso V, Mangoo-Karim R, Evan A, McAteer J: Chemical modification of cell proliferation and fluid secretion in renal cysts. Kidney Int 35:1379–1389, 1989 | PubMed |

Extra navigation

.
ADVERTISEMENT